Functional alterations in NO, PGI2 and EDHF pathways in the aortic endothelium after myocardial infarction in rats

European Journal of Heart Failure

Volumn 8, Issue 8, 2006, Pages 769-776

  Csanyi, Gabor ^a   Bauer, Michael ^b   Dietl, Wolfgang ^b   Lomnicka, Magdalena ^a   Stepuro, Tatiana ^a   Podesser, Bruno K ^b   Chlopicki, Stefan ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

EDHF; Endothelial dysfunction; Gender; Heart failure; NO; PGI2

Indexed keywords

NITRIC OXIDE; PROSTACYCLIN; BIOLOGICAL FACTOR; CYTOCHROME P450; ENDOTHELIUM DEPENDENT HYPERPOLARIZATION FACTOR; ENDOTHELIUM-DEPENDENT HYPERPOLARIZATION FACTOR; POTASSIUM CHANNEL; PROSTAGLANDIN SYNTHASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM; FEMALE; GENDER; HEART FAILURE; HEART INFARCTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; THORACIC AORTA; VASODILATATION; ANIMAL; AORTA; HEART VENTRICLE REMODELING; METABOLISM; PATHOPHYSIOLOGY; SPRAGUE DAWLEY RAT; UPREGULATION;

ANIMALS; AORTA; BIOLOGICAL FACTORS; CYTOCHROME P-450 ENZYME SYSTEM; ENDOTHELIUM; EPOPROSTENOL; FEMALE; MALE; MYOCARDIAL INFARCTION; NITRIC OXIDE; POTASSIUM CHANNELS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RATS; RATS, SPRAGUE-DAWLEY; UP-REGULATION; VENTRICULAR REMODELING;

EID: 33751197275     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2006.09.011     Document Type: Article

References (29)

1. Davila D.F., Nunez T.J., Odreman R., and de Davila C.A. Mechanisms of neurohormonal activation in chronic congestive heart failure: pathophysiology and therapeutic implications. Int J Cardiol 101 (2005) 343-346
2. Kubo S.H., Rector T.S., Bank A.J., Williams R.E., and Heifetz S.M. Endothelium-dependent vasodilation is attenuated in patients with heart failure. Circulation 84 (1991) 1589-1596
3. Tentolouris C., Tousoulis D., Antoniades C., et al. Endothelial function and proinflammatory cytokines in patients with ischemic heart disease and dilated cardiomyopathy. Int J Cardiol 94 (2004) 301-305
4. Belardinelli R., Faccenda E., Volpe L., Balestra S., and Perna G. Exercise training as a form of cardiovascular therapy in chronic heart failure. Ital Heart J 1 (2000) 653-655
5. Drexler H. Endothelium as a therapeutic target in heart failure. Circulation 98 (1998) 2652-2655
6. Mulder P., Richard V., Derumeaux G., et al. Role of endogenous endothelin in chronic heart failure: effect of long-term treatment with an endothelin antagonist on survival, hemodynamics, and cardiac remodeling. Circulation 96 (1997) 1976-1982
7. Bauersachs J., Bouloumie A., Fraccarollo D., Hu K., Busse R., and Ertl G. Endothelial dysfunction in chronic myocardial infarction despite increased vascular endothelial nitric oxide synthase and soluble guanylate cyclase expression: role of enhanced vascular superoxide production. Circulation 100 (1999) 292-298
8. Gschwend S., Buikema H., Henning R.H., Pinto Y.M., de Z.D., and van Gilst W.H. Endothelial dysfunction and infarct-size relate to impaired EDHF response in rat experimental chronic heart failure. Eur J Heart Fail 5 (2003) 147-154
9. Baggia S., Perkins K., and Greenberg B. Endothelium-dependent relaxation is not uniformly impaired in chronic heart failure. J Cardiovasc Pharmacol 29 (1997) 389-396
10. da Cunha C.V., Stefanon I., and Mill J.G. Role of nitric oxide in mediating cardiovascular alterations accompanying heart failure in rats. Can J Physiol Pharmacol 82 (2004) 372-379
11. Mulder P., Elfertak L., Richard V., et al. Peripheral artery structure and endothelial function in heart failure: effect of ACE inhibition. Am J Physiol 271 (1996) H469-H477
12. Saito T., Rodger I.W., Shennib H., Hu F., Tayara L., and Giaid A. Cyclooxygenase- 2 (COX-2) in acute myocardial infarction: cellular expression and use of selective COX-2 inhibitor. Can J Physiol Pharmacol 81 (2003) 114-119
13. Malmsjo M., Bergdahl A., Zhao X.H., et al. Enhanced acetylcholine and P2Y-receptor stimulated vascular EDHF-dilatation in congestive heart failure. Cardiovasc Res 43 (1999) 200-209
14. Ontkean M., Gay R., and Greenberg B. Diminished endothelium-derived relaxing factor activity in an experimental model of chronic heart failure. Circ Res 69 (1991) 1088-1096
15. Ho K.K., Anderson K.M., Kannel W.B., Grossman W., and Levy D. Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation 88 (1993) 107-115
16. Mendelsohn M.E. Genomic and nongenomic effects of estrogen in the vasculature. Am J Cardiol 90 (2002) 3F-6F
17. Mendelsohn M.E., and Karas R.H. The protective effects of estrogen on the cardiovascular system. N Engl J Med 340 (1999) 1801-1811
18. Woodman O.L., and Boujaoude M. Chronic treatment of male rats with daidzein and 17 beta-oestradiol induces the contribution of EDHF to endothelium-dependent relaxation. Br J Pharmacol 141 (2004) 322-328
19. Pfeffer M.A., Pfeffer J.M., Fishbein M.C., et al. Myocardial infarct size and ventricular function in rats. Circ Res 44 (1979) 503-512
20. Trescher K., Bernecker O., Fellner B., et al. Adenovirus-mediated overexpression of inhibitor kappa B-alpha attenuates postinfarct remodeling in the rat heart. Eur J Cardiothorac Surg 26 (2004) 960-967
21. Teerlink J.R., Gray G.A., Clozel M., and Clozel J.P. Increased vascular responsiveness to norepinephrine in rats with heart failure is endothelium dependent. Dissociation of basal and stimulated nitric oxide release. Circulation 89 (1994) 393-401
22. Brandes R.P., Walles T., Koddenberg G., Gwinner W., and Mugge A. Endothelium-dependent vasodilatation in Sprague-Dawley rats with postinfarction hypertrophy: lack of endothelial dysfunction in vitro. Basic Res Cardiol 93 (1998) 463-469
23. Mian K.B., and Martin W. Differential sensitivity of basal and acetylcholine-stimulated activity of nitric oxide to destruction by superoxide anion in rat aorta. Br J Pharmacol 115 (1995) 993-1000
24. Belch J.J., Bridges A.B., Scott N., and Chopra M. Oxygen free radicals and congestive heart failure. Br Heart J 65 (1991) 245-248
25. Omland T., Lie R.T., Aakvaag A., Aarsland T., and Dickstein K. Plasma endothelin determination as a prognostic indicator of 1-year mortality after acute myocardial infarction. Circulation 89 (1994) 1573-1579
26. Chen Z., Yuhanna I.S., Galcheva-Gargova Z., Karas R.H., Mendelsohn M.E., and Shaul P.W. Estrogen receptor alpha mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen. J Clin Invest 103 (1999) 401-406
27. Fisslthaler B., Popp R., Kiss L., et al. Cytochrome P450 2C is an EDHF synthase in coronary arteries. Nature 401 (1999) 493-497
28. Campbell W.B. New role for epoxyeicosatrienoic acids as anti-inflammatory mediators. Trends Pharmacol Sci 21 (2000) 125-127
29. Shimokawa H., Yasutake H., Fujii K., et al. The importance of the hyperpolarizing mechanism increases as the vessel size decreases in endothelium-dependent relaxations in rat mesenteric circulation. J Cardiovasc Pharmacol 28 (1996) 703-711